Medical Health: Society: News: Hankyoreh



[ad_1]

93% of those under 65 a month ago ‘agreed’
President Moon’s partner, public vaccination on the 23rd
“Increase the consent rate of people with underlying diseases
Need to give benefits to inoculators “

Choi Eun-hwa, Chairman of the Committee of Vaccination Specialists (right), explained the cases of blood clotting disorders discovered after the vaccination of AstraZeneca Corona 19 in a regular briefing on the national outbreak and the vaccination status of Corona 19 held at the Centers for Disease Control.  and Prevention in Cheongju City, Chungbuk, on the afternoon of December 22.  On the left is Jeong Eun-kyung, director of the Centers for Disease Control and Prevention (Defense Countermeasures Headquarters).  Yunhap news

Choi Eun-hwa, Chairman of the Committee of Vaccination Specialists (right), explained the cases of blood clotting disorders discovered after the vaccination of AstraZeneca Corona 19 in a regular briefing on the national outbreak and the vaccination status of Corona 19 held at the Centers for Disease Control. and Prevention in Cheongju City, Chungbuk, on the afternoon of December 22. On the left is Jeong Eun-kyung, director of the Centers for Disease Control and Prevention (Defense Countermeasures Headquarters). Yunhap news

The consent rate for vaccination with the AstraZeneca Corona 19 vaccine among people 65 years of age or older in hospitals and nursing facilities, as of day 23, was found to be only 76.9%. Experts warned that to regain confidence in the AstraZeneca vaccine, it is time to mark a turning point, such as the involvement of social leaders in vaccination. The Corona 19 Vaccination Response Advocacy Team announced on the 22nd that of 370,5061 residents and workers 65 years and older hospitalized in hospitals and nursing facilities nationwide, 28,8365 people accepted the vaccination. The consent rate is 76.9%. As of last month 20, the consent rate for 300,000 people under 65 who received the AstraZeneca vaccine at the same facility was low compared to 93.6%. Vaccination against AstraZeneca was once postponed in Korea, on the grounds that there was insufficient data to demonstrate the effectiveness of the elderly over 65 years of age, and the situation that vaccination was suspended and resumed due to a blood clot in major European countries could have overlapping effects. Korea Centers for Disease Control and Prevention (KCDC) Commissioner Jeong Eun-gyeong said, “I think people’s feelings of unease were reflected in the difference in the rate of consent to vaccination ( since a month ago)”. However, in this survey, the consent rate for hospitalized patients and residents was 60-70%, but 90% of workers agreed. I see it that way, “he added. Rather than anxiety about specific vaccines, it is said that old age may reflect the characteristics of the underlying disease group. Experts advised that social leaders should actively initiate public vaccination to restore confidence in the AstraZeneca vaccine, which has been repeatedly confirmed to be problem-free in its preventive effect and safety. In particular, it is worth noting whether the AstraZeneca vaccine on the 23rd by President Moon Jae-in and his wife will be a turning point in the recovery of confidence. President Moon said in a headline address at the meeting of chiefs and advisers held at the Blue House that day: “I hope that people will also respond to vaccination without suspecting the safety of the vaccine.” our society as a whole while protecting our own security. It is also a way to maintain it. “Jeong Jae-hoon, professor at Gachon University School of Medicine (Preventive Medicine), said:” There is a problem that the consent rate has decreased to this point, although subjects most in need of vaccination are the elderly with underlying diseases. “We need a plan to restore confidence that meets the public level, such as vaccinating all social leaders,” he said. Ahn Do-hyun, president of the Korean Communication Society of Health (Professor of Journalism and Public Relations, Jeju National University) said: “The explanation that ‘the benefit outweighs the risk’ is a way of speaking among scientists. The public should be clearly told, like, ‘ It is a lie to die if they give you a vaccine. ‘ There should be many cases where celebrities that people identify with, especially celebrities who interact with the public, are vaccinated. I do, ”he advised. Some pointed out that a way needs to be found to benefit vaccines. Won-seok Choi, professor at the Ansan Hospital (Infectious Internal Medicine) of the University of Korea, said: “The AstraZeneca vaccine shows a prevention effect of more than 70% even with a vaccine. Therefore, people who have been vaccinated can consider ways to make a difference in health, such as exempting self-isolation even if they have close contact with an infected person. “He added:” If vaccination of those who preceded it in priority is delayed, you need to move quickly to vaccinating the next target group and show that it is actually safe. “Professor Jeong Jae-hoon said,” The introduction of a ‘vaccine passport’, which gives more freedom to travel abroad by demonstrating the fact of vaccination, it can help increase the vaccination rate. “On the other hand, a multinational pharmaceutical company AstraZeneca announced interim results showing 79% prevention of COVID-19 infection, 100% severe progression and prevention effect of hospitalization in the phase 3 clinical trial of the AstraZeneca vaccine in the US on the 22nd (local time). It participated in a clinical trial involving 32,449 people of various races, and AstraZeneca said it had an infection-preventing effect of more than 80%. In the safety assessment, he explained that there was no evidence of an increase in thrombosis-related diseases in the vaccinated group and that no cerebral sinus thrombosis (CVST) was found. AstraZeneca said it will submit clinical trial results to the US Food and Drug Administration (FDA) next week to obtain approval for emergency use in the United States. By Kim Ji-hoon, Seo Hye-mi, and Lee Wan, Staff Reporter [email protected]



[ad_2]